An artificial intelligence-powered biotechnology company that provides molecular profiling services and precision oncology solutions. The company develops and commercializes molecular intelligence products and platforms that use whole exome, transcriptome, and genome sequencing combined with AI and machine learning algorithms to transform cancer detection, diagnosis, and treatment. Caris also offers pharmaceutical research and development services to biopharmaceutical customers.